ArticlePakistan journal of medical sciences2025
Frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 Diabetics.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Sea Buckthorn (Foods (Basel, Switzerland) · 2026Review
- Evaluation of the relationship between glycated hemoglobin (HbA1c) levels and diabetes and other diseases: A retrospective study.Pakistan journal of medical sciences · 2026Article
- Unlocking the Therapeutic Potential ofMedicina (Kaunas, Lithuania) · 2025Article
- Association between Disorders of Lipid Metabolism and Oculopathy: An Overview.International journal of medical sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 diabetics. Methods: This cross-sectional study was conducted in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute Lahore from January-October 2023. Type-2 diabetics regardless of age were evaluated by fasting lipid profile and were further evaluated by BMI, HbA1c and smoking. Exclusion criteria was patients taking lipid lowering drugs and all other causes of secondary dyslipidemias other than diabetes. Data for normally distributed quantitative variables was presented by Mean±SD, and for skewed measures were presented by using median (IQR). Dyslipidemia was described for each trait by using frequency and percentages. Results: A total of two hundred and twelve subjects were included in the study with the mean age of 53.4±9.1 years. About 96.6% patients were found to have different patterns of dyslipidemia that also showed positive association with smoking, uncontrolled HbA1c and obesity (p < 0.001). Conclusion: There is very high prevalence of dyslipidemia among Type-2 diabetics especially those who are smokers, with poor glycemic control and overweight/obese. Early screening of patients for dyslipidemia with lifestyle modifications and treatment of dyslipidemia can reduce risk of CVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.